No Data
No Data
Extrawell Pharmaceutical Holdings' Auditor to Leave After Expiration of Term of Service
Extrawell Pharmaceutical Extends Loan Agreement, Grants New Loan Facility
Extrawell Phar (00858) plans to provide further financial support to Jingsheng.
Extrawell Phar (00858) announced that it has granted the first and second loans to the borrower, JinSheng Yu Limited, according to the announcement.
EXTRAWELL PHAR: Annual Report 2024
Extrawell Phar (00858.HK) had a net loss of HKD 162 million for the year.
On June 28th, Glory Medical announced that for the fiscal year ended on March 31, 2024, the company's revenue was HKD 59.1 million, compared to HKD 72.58 million in the same period last year; the annual loss was HKD 162 million, compared to a profit of HKD 130 million in the same period last year.
Express News | Extrawell Pharmaceutical - FY Revenue HK$59.1 Mln Vs HK$72.6 Mln
No Data
